Ascend Wellness Holdings (AAWH) Operating Expenses (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Operating Expenses of $42.3 million for Q1 2026, up 14.19% year-over-year from $37.1 million in Q1 2025, and down 6.54% quarter-over-quarter from $45.3 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Operating Expenses (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Operating Expenses history runs 7 years deep, the most recent figure standing at $42.3 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 14.19% year-over-year to $42.3 million; the TTM figure through Mar 2026 stood at $175.0 million (up 4.71% YoY), while the FY2025 annual figure was $186.7 million, up 4.02% from the prior year.
- Operating Expenses for Q1 2026 stood at $42.3 million, down from $45.3 million in the prior quarter.
- The five-year high for Operating Expenses was $49.5 million in Q1 2024, with the low at $33.6 million in Q2 2022.
- The 5-year median for Operating Expenses is $40.8 million (2024), against an average of $40.7 million.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses sank 38.0% in 2022, then jumped 39.53% in 2024.
- Ascend Wellness Holdings' Operating Expenses stood at $36.1 million in 2022, then surged by 30.02% to $47.0 million in 2023, then dropped by 13.21% to $40.8 million in 2024, then advanced by 11.1% to $45.3 million in 2025, then declined by 6.54% to $42.3 million in 2026.
- Business Quant data shows AAWH's Operating Expenses at $42.3 million in Q1 2026, $45.3 million in Q4 2025, and $44.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Ascend Wellness Holdings | 85.26 Mn | 18.26 Mn | 45.49 Mn | 40.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.21 Mn |
| Mar 31, 2026 | 42.34 Mn |
| Dec 31, 2025 | 45.30 Mn |
| Sep 30, 2025 | 44.93 Mn |
| Jun 30, 2025 | 42.39 Mn |
| Mar 31, 2025 | 37.08 Mn |
| Dec 31, 2024 | 40.77 Mn |
| Sep 30, 2024 | 46.15 Mn |
| Jun 30, 2024 | 43.10 Mn |
| Mar 31, 2024 | 49.46 Mn |
| Dec 31, 2023 | 46.98 Mn |
| Sep 30, 2023 | 40.01 Mn |
| Jun 30, 2023 | 36.30 Mn |
| Mar 31, 2023 | 35.45 Mn |
| Dec 31, 2022 | 36.13 Mn |
| Sep 30, 2022 | 34.16 Mn |
| Jun 30, 2022 | 33.57 Mn |
| Mar 31, 2022 | 38.23 Mn |
| Dec 31, 2021 | 31.57 Mn |
| Sep 30, 2021 | 29.34 Mn |